DE BERNARDI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 5.802
AS - Asia 4.077
EU - Europa 2.888
SA - Sud America 445
AF - Africa 49
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 5
Totale 13.284
Nazione #
US - Stati Uniti d'America 5.658
SG - Singapore 1.329
VN - Vietnam 1.189
IT - Italia 774
CN - Cina 718
HK - Hong Kong 503
RU - Federazione Russa 473
BR - Brasile 377
DE - Germania 367
SE - Svezia 248
IE - Irlanda 243
UA - Ucraina 166
GB - Regno Unito 163
CA - Canada 106
AT - Austria 88
FI - Finlandia 76
FR - Francia 73
IN - India 62
KR - Corea 49
TR - Turchia 42
CH - Svizzera 40
ID - Indonesia 37
PL - Polonia 37
NL - Olanda 31
BD - Bangladesh 30
DK - Danimarca 30
JP - Giappone 29
AR - Argentina 28
ZA - Sudafrica 26
ES - Italia 24
MX - Messico 19
AU - Australia 15
IQ - Iraq 14
BE - Belgio 13
CO - Colombia 10
CZ - Repubblica Ceca 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
EC - Ecuador 9
BG - Bulgaria 8
MA - Marocco 7
TW - Taiwan 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
PK - Pakistan 6
DZ - Algeria 5
JO - Giordania 5
LT - Lituania 5
DO - Repubblica Dominicana 4
JM - Giamaica 4
NP - Nepal 4
RO - Romania 4
BO - Bolivia 3
BY - Bielorussia 3
EU - Europa 3
IL - Israele 3
IR - Iran 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PA - Panama 3
PH - Filippine 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
KE - Kenya 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
PE - Perù 2
PT - Portogallo 2
SC - Seychelles 2
TH - Thailandia 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
Totale 13.280
Città #
Ann Arbor 946
Singapore 612
Woodbridge 505
Hong Kong 492
Ashburn 489
Fairfield 384
Hanoi 351
Ho Chi Minh City 348
Houston 334
Chandler 326
Frankfurt am Main 247
Dublin 236
Milan 223
Wilmington 220
Jacksonville 178
Dearborn 152
Cambridge 147
New York 147
Seattle 139
Santa Clara 135
Beijing 123
Dallas 104
Princeton 100
Hefei 98
Los Angeles 98
Nanjing 67
Vienna 63
Moscow 51
Chicago 46
Shanghai 44
The Dalles 44
Munich 42
Seoul 42
Lawrence 41
São Paulo 40
Altamura 36
Da Nang 35
Haiphong 34
London 33
Buffalo 32
Lachine 32
San Diego 32
Ottawa 31
Fremont 30
Quận Bình Thạnh 30
Council Bluffs 29
Boardman 28
Jakarta 27
Guangzhou 26
Warsaw 26
Hải Dương 25
Thái Nguyên 25
Dong Ket 24
Monza 24
Rome 24
Biên Hòa 22
Nanchang 22
Lissone 21
Nuremberg 20
Tokyo 20
Brooklyn 19
Quận Một 19
Stockholm 18
Amsterdam 17
Toronto 17
Changsha 16
Denver 16
Can Tho 15
Ha Long 15
Ravenna 15
Helsinki 14
Salt Lake City 14
Tianjin 14
Washington 14
Brussels 13
Chennai 13
Johannesburg 13
Ninh Bình 13
Poplar 13
Vũng Tàu 13
San Francisco 12
Turku 12
Lang Son 11
Montreal 11
Naples 11
Andover 10
Atlanta 10
Erlenbach 10
Hebei 10
Jiaxing 10
Lappeenranta 10
Orem 10
Quận Năm 10
Shenyang 10
Boston 9
Jinan 9
Phủ Lý 9
Rio de Janeiro 9
Tashkent 9
Brno 8
Totale 8.803
Nome #
Implication of tumor morphology and MRI characteristics on the accuracy of automated versus human segmentation of GBM areas 1.224
PET textural features stability and pattern discrimination power for radiomics analysis: An “ad-hoc” phantoms study 469
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 415
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 391
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 387
Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211 314
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma 292
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 269
Metodi di segmentazione avanzata: applicazioni in oncologia 265
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 262
PET quantification: strategies for partial volume correction 255
An optimized protocol for correlation of PET-FDG and pCASL data in mild cognitive impairment (MCI) patients 246
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 242
Performances of Principal Component Analysis for the extraction of respiratory signal from Time-of-Flight PET coincidences stream 236
Reconstruction of uptake patterns in PET: The influence of regularizing prior 225
Spontaneous and iatrogenic ARIA: Mechanistic insights from CAA‐related inflammation 217
Motion-Tracking Hardware and Advanced Applications in PET and PET/CT 216
A Dedicated Tomographic Image Reconstruction Algorithm for Integration-Mode Detector Configuration in Ion Imaging 210
Radiomics in PI-RADS 3 Multiparametric MRI for Prostate Cancer Identification: Literature Models Re-Implementation and Proposal of a Clinical–Radiological Model 207
Preliminary assessment of semiautomated segmentation tool for GBM neurosurgery: a BraTS-Toolkit approach 207
Analysis of different detector and electronics defects on F18-FDG images 207
Quantitative performance of iterative algorithms, with and without PSF and TOF, in the conditions of a dynamic cardiac 13N-ammonia study 206
4D ML reconstruction as a tool for volumetric PET-based treatment verification in ion beam radiotherapy 204
Technical Note: A new zeolite PET phantom to test segmentation algorithms on heterogeneous activity distributions featured with ground-truth contours 202
Development of a software platform for evaluating automatic PET segmentation methods 201
Lesion quantification in oncological positron emission tomography: A maximum likelihood partial volume correction strategy 195
Validation of brain 18FDG-PET and pCASL joint analysis tool: a ROI-based approach 195
The use of zeolites to generate PET phantoms for the validation of quantification strategies in oncology 193
Towards the Definition of Radiomic Features and Clinical Indices to Enhance the Diagnosis of Clinically Significant Cancers in PI-RADS 4 and 5 Lesions 189
Joint Segmentation and Quantification of Oncological Lesions in PET/CT: Preliminary Evaluation on a Zeolite Phantom 188
Proposal of a 4D ML Reconstruction Strategy for PET-based Treatment Verification in Ion Beam Radiotherapy 188
Resolution recovery in PET during AWOSEM reconstruction: a performance evaluation study 186
GMM guided automated level set algorithm for PET image segmentation 186
Radiomics and liver: Where we are and where we are headed? 184
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: Validation of the 18F-FDG PET line 184
ML segmentation strategies for object interference compensation in FDG-PET lesion quantification 181
Optimized Bayes variational regularization prior for 3D PET images 181
Artificial intelligence for precision medicine in autoimmune liver disease 175
Time of flight increases noise in MLEM PET reconstructions stopped early: Theory, simulations and phantoms 175
Geometrical interpretation of TOF PET raw data in commercial PET-CT scanner for SNR optimization 173
Background based Gaussian mixture model lesion segmentation in PET 172
Towards a standard for the evaluation of PET Auto-Segmentation methods: requirements and implementation 172
Evaluation of a 2D UNet-Based Attenuation Correction Methodology for PET/MR Brain Studies 171
First clinical investigation of a 4D maximum likelihood reconstruction for 4D PET-based treatment verification in ion beam therapy 166
A simple contrast matching rule for osem reconstructed pet images with different time of flight resolution 164
Optimization of rapid acquisition with relaxation enhancement (RARE) pulse sequence parameters for 19F-MRI studies 161
Clinical investigations of a 4D ML reconstruction strategy for PET-based treatment verification in ion beam therapy 160
Model based lesion segmentation in FDG-PET from raw data and clinical images 156
Iterative joint segmentation and quantification of oncological lesions in PET-CT 155
Tuning of a 4D ML reconstruction strategy for treatment verification in ion beam radiotherapy 153
Protocol assessment for quantitative 19F MRI of low concentrated compounds on a preclinical 7T MRI scanner: preliminary evaluations and results 149
Evaluation of frequency-distance relation validity for FORE optimization in 3D PET 148
PET-CT scanner characterization for PET raw data use in biomedical research 144
Design of a Benchmark Platform for Evaluating PET-based Contouring Accuracy in Oncology Applications 144
Regularized ML reconstruction for time/dose reduction in 18F-fluoride PET/CT studies 143
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: validation on 18F-FDG PET data 141
Regional MLEM reconstruction strategy for PET-based treatment verification in ion beam radiotherapy 138
PET-based dosimetry in particle therapy: assessing the feasibility of regional MLEM reconstruction as a quantification tool 132
Assessment of zeolites for lesion simulation in PET-CT 125
Non-invasive imaging biomarkers in chronic liver disease 124
“Under the hood”: artificial intelligence in personalized radiotherapy 109
High Field 19F MRI: optimization of Rapid Acquisition with Relaxation Enhancement (RARE) sequences to improve the sensitivity on a preclinical 7T MRI scanner 105
Identification of Alzheimer’s disease with 18F-FDG-PET and MRI pCASL in MCI and SCD subjects: the CAPE study 53
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT 25
Totale 13.652
Categoria #
all - tutte 42.701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.701


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021707 0 0 0 0 0 80 113 127 103 95 83 106
2021/2022659 53 75 82 30 29 36 38 70 25 47 65 109
2022/20231.234 119 319 132 114 96 184 18 74 89 29 31 29
2023/20241.031 45 54 30 71 119 203 157 27 104 36 28 157
2024/20253.660 114 265 134 118 178 110 204 108 214 366 385 1.464
2025/20262.927 525 453 457 593 670 229 0 0 0 0 0 0
Totale 13.652